Non Insulin Dependent Diabetes
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
Curcumin Supplementation and Patients With Type 2 Diabetes
Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations